Success Stories: With the Premium Processing Upgrades, We Assisted an Associate Professor in the Field of Biotechnology in Securing NIW and EB-1A Approvals Hassle-free
Client’s Testimonial:
“Thank you for the kind message. Indeed, it is a very happy moment to see the approval notice.”
On August 1st, 2023, and October 23rd, 2023, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approval for an Associate Professor in the field of Biotechnology (Approval Notice).
General Field: Biotechnology
Position at the Time of Case Filing: Associate Professor
Country of Origin: India
Country of Residence at the Time of Filing: Saudi Arabia
Approval Notice Date: August 1st, 2023 (NIW) and October 23rd, 2023 (EB-1A)
Processing Time: 5 days (NIW) and 7 days (EB-1A) (Premium Processing Requested for both)
Case Summary:
Our eligible client is one of the few prominent bioelectrochemistry and bioprospecting experts in biotechnology, with a track record of success and impact in these fields. He is most recognized for discovering naturally derived small compounds that can be used to build anti-SARS-CoV-2 therapies. With a Ph.D. in botany, he is a highly qualified advanced degree scientist with extensive experience in the field of biotechnology. When he hired the North America Immigration Law Group to file an EB-2 NIW (National Interest Waiver) petition on his behalf, we further discussed his research on identifying and characterizing advanced materials for use in biomedical and environmental endeavors.
After thoroughly going over his research background, we concluded that his bioelectrochemistry and bioprospecting research addresses some of our nation’s and the world’s most pressing issues, including the ongoing mission to improve therapeutic initiatives to combat health crises like cancer, the need for advanced new methods of identifying harmful heavy metal pollutants, the lack of effective and sensitive electrochemical sensors for environmental monitoring, and the prevention of harm to human health and the environment. Therefore, we agreed to take his case and prepare a strong NIW case demonstrating that he will continue to bring significant benefits to the United States.
- We noted that the 207 peer-reviewed scientific articles, 1 book chapter, and 5 books he published, all together gathered 4,018 citations by dependent and independent researchers, demonstrating that his publications are widely recognized and relied upon in his preferred field.
- We also specified his active and practical engagement as a judge of other experts' work in the field. He has conducted 14 peer reviews to date, and he obviously fits this requirement based on the data presented.
Since we were well aware of how he intends to continue his work in biotechnology in the United States. As proof of this, we presented a personal letter from him outlining the goals of his future research in the United States and furthered with his EB-1A case.
We emphasized the fact that he has already made significant contributions to national interest by synthesizing green nanoparticles from desert rose extracts for highly sensitive electrochemical sensors, and obtaining small molecules from natural sources for use in drug development. Not only has he demonstrated that he fits at least three of the regulatory requirements, but the evidence as a whole also indicates his national and worldwide renown and position at the pinnacle of his field.
Our team’s efforts successfully paid off in conveying the USCIS of our client’s expansive experience in his chosen field. Therefore, we would like to congratulate him on securing both the I-140 approvals and thanks to the Premium Processing service upgrade for his EB-1A case, which was adjudicated in only 7 days instead of 9-12 months. We sincerely thank our client for choosing our law firm and giving us the opportunity to be a part of two of his great approval stories.